Next Article 
Journal of Clinical Microbiology, September 2001, p. 3025-3030, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3025-3030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Detection of B Virus Antibody in Monkey Sera Using
Glycoprotein D Expressed in Mammalian Cells
Kiyoshi
Tanabayashi,*
Ryozaburo
Mukai, and
Akio
Yamada
Tsukuba Primate Center for Medical Science,
National Institute of Infectious Diseases, 1 Hachimandai, Tsukuba,
Ibaraki 208-0843, Japan
Received 27 December 2000/Returned for modification 8 April
2001/Accepted 17 June 2001
 |
ABSTRACT |
The gene encoding glycoprotein D (gD) of the monkey B
virus (Cercopithecine herpesvirus 1) was
cloned into a mammalian expression vector, pcDNA3.1(
), and the
recombinant plasmid DNA was transfected into COS7 cells. The expression
of gD in transfected COS7 cells was detected by indirect
immunofluorescence assay or radioimmunoprecipitation analysis (RIPA).
Although the expressed gD protein was revealed to react well with sera
from monkeys naturally infected with B virus by RIPA, some sera showed
reduced reactivity when analyzed by the Western blotting (WB)
method. Some sera also showed relatively high background when the WB
was performed using gD expressed from recombinant plasmid. The mutant
gD protein lacking the transmembrane domain (TM) and cytoplasmic tail
(CT) was next expressed in COS7 cells. The mutant protein was secreted
into culture medium without apparent loss of the antigenicity. Using
the secretory form of the gD protein as antigen in dot blot analysis,
sera from B virus-infected monkeys were shown to react with the mutant
protein without nonspecific reaction. Since the recombinant gD or its
derivative lacking TM and CT could be expressed in mammalian cells with
proper antigenicity, these antigens appeared to be useful for
serological detection of B virus infection in monkeys.
 |
INTRODUCTION |
B virus (Cercopithecine
herpesvirus 1) is a member of subfamily
Alphaherpesvirinae and is classified into the genus
Simplexvirus together with human herpes simplex virus 1 (HSV-1) and HSV-2 (8). It is enzootic in rhesus
monkeys (Macaca mulatta), cynomolgus monkeys
(Macaca fascicularis), and other Asiatic species of the genus Macaca. Clinical manifestation of B virus infection is
generally mild in these natural hosts. Human infections with this
virus, although the incidence is quite low, result in severe and
sometimes fatal encephalitis (14, 15). Since nonhuman
primates are important experimental animals for biomedical research, it
is very important to reduce the risk of B virus infection in animal
handlers, laboratory workers, and researchers. For this purpose,
efforts have been made to establish B virus-free monkey colonies
(6, 12, 13).
Serological diagnosis of B virus infection in macaques is usually
conducted by antibody detection using enzyme-linked immunosorbent assay
(ELISA) or Western blotting (WB) analysis. The antigens used in these
serological tests are prepared from B virus-infected cells; however,
for propagation of this virus a special biosafety containment is
required, since the virus is classified as a class 4 pathogen. Viruses
antigenically closely related to B virus, such as human HSV-1,
herpesvirus papio 2, or simian agent 8 (SA8), thus have been used as
alternative antigens for detection of B virus infection (7, 10,
15). Another way to prepare the antigens for serological tests
is expression of a viral protein by means of the recombinant DNA
technique. A part of the C terminus of glycoprotein G (gG)
of B virus expressed in Escherichia coli as a fusion protein
with glutathione S-transferase has been shown to react with
sera taken from B virus-infected monkeys (9). Since
glycosylation of the glycoprotein does not
take place in bacteria, it seems likely that the tertiary structure of
the protein is altered and that the antigenic property of the protein
is possibly affected. We therefore attempted to express one of the
essential and major viral glycoproteins, gD, of B virus in
mammalian cells and to assess the possibility of using the recombinant
gD protein for serodiagnosis of B virus infection in macaques.
 |
MATERIALS AND METHODS |
Cells.
COS7 cells were maintained in Dulbecco's modified
Eagle's minimal essential medium (DMEM) supplemented with 10% fetal
bovine serum.
Construction of gD expressing recombinant plasmid.
A
recombinant plasmid carrying the B virus gD gene, pBlueSK+2.6
(1), was generously provided by Alice Bennett (Defense Evaluation and Research Agency, Chemical and Biological Defense, Salisbury, United Kingdom). The DNA fragment including the
entire region of the open reading frame of the gD gene was excised by CspI digestion and blunted by T4 DNA polymerase, followed by
digestion with XhoI. The resulting DNA fragment
was subcloned into the XhoI-EcoRV site of
pcDNA3.1(
) expression vector (Invitrogen, Carlsbad, Calif.). The recombinant plasmid, designated pBgD, was introduced into E. coli DH5
cells, and the amplified plasmid DNA was
purified with a plasmid kit (Qiagen) according to the manufacturer's instructions.
Construction of mutant gD-expressing recombinant plasmid.
To
delete the transmembrane domain (TM) and cytoplasmic tail (CT) of
gD, PCR was performed using the forward oligonucleotide primer S
(5'-CCTGGTACCGCACGAGCGAC-3') and the reverse
primer R (5'-CACGGTACCTCAATGATGATGATGATGATGGGGGCCCTGGATGGTGAC-3') and recombinant plasmid pBlueSK+2.6 as a template. Both primers contained a KpnI recognition site (underlined). The reverse
primer was designed to contain a stop codon (boldface type) and six
extra histidine codons (italic letters). The PCR fragment was
digested with KpnI and cloned into KpnI sites of
pBgD. The nucleotide sequence of the resulting plasmid DNA was
confirmed by sequencing analysis using an ABI PRISM 310 Genetic
Analyzer. The recombinant plasmid, designated pBgDdTM, could encode
332 amino acids of gD. The construction strategy and protein structures
are schematically shown in Fig. 1A and B,
respectively.


View larger version (34K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Strategy of construction of recombinant
plasmid pBgDdTM. PCR was performed using pBlueSK+2.6
(1), which contains the gD gene of B virus, as the
template together with primers S and R. The PCR product (shaded column)
was replaced with a KpnI-KpnI
fragment of pBgD. (B) Schematic representation of gD and
gDdTM of B virus. The numbers indicate amino acid residues. The
shaded columns represent the signal peptide (SP), TM, and CT. Positions
of potential N-glycosylation sites (bar) and cysteine
residues (inverted triangles) are illustrated on each of the columns.
|
|
Transient expression of wild-type and deletion mutant gD.
The recombinant plasmid DNA, pBgD or pBgDdTM, was introduced
into COS7 cells by using Lipofectamine Plus Reagent (Gibco-BRL) according to the protocol recommended by the manufacturer.
Immunofluorescent staining.
COS7 cells grown on cover
glasses were transfected with recombinant plasmid DNAs as described
above. The cells were fixed with cold acetone and incubated with 1:100
diluted anti-gD monospecific antibody against SA8 [anti-gD(SA8)]
(4) generously provided by R. Eberle (Oklahoma State
University), followed by incubation with 1:100 diluted goat antibody
against rabbit immunoglobulin G (IgG) conjugated with fluorescein
isothiocyanate (Cappel, Aurora, Ohio). The stained cells were observed
under a UV microscope.
Radioimmunoprecipitation analysis (RIPA).
COS7 cells
transfected with recombinant plasmid DNAs were metabolically labeled
with methionine- and cysteine-deficient Dulbecco's modified Eagle's
minimal essential medium containing 100 µCi of the Redivue Pro-mix
L-[35S] in vitro cell-labeling mix (Amersham
Pharmacia Biotech, Little Chalfont, United Kingdom) per ml for 2 or 5 h at 40 h after transfection. The radiolabeled cells
were lysed with cell dissociation buffer (10 mM Tris-HCl [pH 8.0],
250 mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate) and
clarified by centrifugation (11). The cell extract was
mixed with anti-gD(SA8), anti-B virus antibody (kindly provided by R. Eberle), or various sera, followed by precipitation with protein
A-Sepharose (Amersham Pharmacia). The precipitates were subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on
10 or 7.5% polyacrylamide gels and were analyzed by the FLA 2000 system (Fuji Film, Tokyo, Japan).
WB analysis.
The cell extract or culture supernatant from
recombinant plasmid DNA-transfected cells separated by SDS-PAGE were
blotted onto polyvinylidene difluoride (PVDF) membrane
(Immun-Blot PVDF; Bio-Rad Laboratories, Hercules, Calif.) with a
semidry blotting system (Bio-Rad Laboratories). After blocking with
BlockAce reagent (Daiiti-Kagaku, Tokyo, Japan), the membranes were
incubated with rabbit anti-gD(SA8) antibody or monkey sera at room
temperature for 1 h. After being washed, the membrane was
incubated with peroxidase-conjugated anti-rabbit or anti-monkey IgG
(Amersham Pharmacia Biotech or Cappel, respectively) at room
temperature for 1 h. The specific signals were visualized using
the ECL Plus Western blotting detection system (Amersham Pharmacia
Biotech) according to the protocol supplied by the manufacturer.
Dot blot analysis.
The secretory form of gD, gDdTM, was
purified from the culture supernatant of COS7 cells transfected with
pBgDdTM by chromatography on HisTrap and HiTrap desalting columns
(Amersham Pharmacia Biotech) according to the manufacturer's protocol.
Five microliters of purified protein, culture fluid of COS7 cells
transfected with recombinant plasmid pBgDdTM, or vector DNA was
directly spotted on the activated PVDF membrane. After blocking by the
BlockAce reagent, the membranes were incubated with monkey sera (1:20) for 1.5 h, followed by incubation with peroxidase-conjugated
anti-monkey IgG (1:1,000; Cappel) at room temperature for 1 h. The
specific signals were visualized by HRP Conjugate Substrate Kit
(Bio-Rad Laboratories) according to the protocol supplied by the manufacturer.
Monkey sera.
Sera were collected from cynomolgus monkeys
raised at the Tsukuba Primate Center for Medical Science, the National
Institute of Infectious Diseases, and stored at
80°C until use.
Eight positive and five negative sera were selected and used throughout
the study. An additional 61 positive and 36 negative sera from
cynomolgus monkeys were also tested in the dot blot analysis. The
presence of antibodies directed to inactivated B virus antigen was
determined at the Corporation for Production and Research of Laboratory
Primates with ELISA (10).
 |
RESULTS |
Expression of gD in mammalian cells.
The recombinant plasmid
DNA, pBgD, or vector DNA was transfected to COS7 cells, and the
transfected cells were examined for the expression of the gD protein by
immunofluorescence staining with anti-gD(SA8) antibody. Significant
fluorescence was observed in cells transfected with pBgD (Fig.
2A, top), but not in cells transfected
with vector DNA (Fig. 2A, bottom). Radioimmunoprecipitation analysis
with anti-gD(SA8) or anti-B virus antibody of the extract prepared from
COS7 cells transfected with pBgD revealed the presence of the
protein with a molecular mass corresponding to that reported previously
(2) (Fig. 2B).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of B virus gD in COS7 cells was analyzed by
indirect immunofluorescence staining (A) and RIPA (B). (A) COS7 cells
transfected with pBgD (upper panel) or pcDNA3.1( ) vector (lower
panel) were fixed with cold acetone and incubated with anti-gD(SA8)
(dilution;1:100), followed by goat anti-rabbit IgG conjugated with
fluorescein isothiocyanate. The cells were observed under a UV
microscope. (B) The recombinant plasmid, pBgD (lanes 1 and 2), or
vector DNA (lanes 3 and 4) was transfected to COS7 cells, and the cell
extracts were precipitated with anti-gD(SA8) (lanes 1 and 3) or rabbit
anti-B virus (lanes 2 and 4). The precipitates were analyzed on a 10%
polyacrylamide gel containing SDS, followed by exposure to an imaging
plate of the FLA 2000 system. The position of gD is indicated on the
left, and molecular mass standards (in kilodaltons) are shown
on the right.
|
|
Reactivity of gD expressed in transfected cells to monkey
sera.
We next attempted to determine whether sera from monkeys
naturally infected with B virus recognized gD expressed in COS7 cells from plasmid DNA. As shown in Fig. 3, the
expressed gD was specifically precipitated with monkey sera which had
been judged to contain antibodies against B virus by ELISA using
inactivated B virus antigen (serum no. 49, 41, 37, 42, 46, 84, 82, and
83). No specific band was detected when sera from uninfected monkeys
were examined (Fig. 3, no. 991 to 995). Since RIPA is time-consuming
and labor-intensive and it also requires the use of radioactive
materials, we have tried to develop other methods without any use of
radioisotopes. To this end, cells transfected with pBgD were lysed
and used as antigen for WB analysis (Fig.
4). In this method, three out of eight
monkey sera reacted well, but the others (no. 41, 46, 49, 83, and 84)
showed significantly reduced reactivity to gD. In addition nonspecific
bands with mobility similar to that of gD were present when some monkey
sera (no. 82 to 84) were reacted with the extracts from COS7 cells
transfected with the pBgD as well as vector DNA.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 3.
Reactivity of recombinant gD to monkey sera in RIPA.
Radiolabeled extracts from COS7 cells transfected with the pBgD (D)
or pcDNA vector DNA (V) were immunoprecipitated with various sera
(dilution, 1:50). Sera from monkeys regarded as B virus-infected (no.
37, 41, 42, 46, 49, 82, 83, and 84) and noninfected (no. 991,992, 993, 994, and 995) were used. Anti-BV serum was also included, and the
position of the gD was indicated on the left of the panel. Molecular
mass standards (in kilodaltons) are shown on the right.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 4.
Reactivity of expressed gD with monkey sera in WB
analysis. The extracts from COS7 cells transfected with pBgD (A) or
pcDNA3.1( ) (B) were examined for reactivity with sera obtained from
monkeys. Sera from monkeys regarded as B virus infected (no. 37, 41, 42, 46, 49, 82, 83, and 84) and noninfected (no. 991,992, 993, 994, and
995) were used. Anti-gD(SA8) serum was also included. The position of
gD (arrow) and molecular mass standards (in kilodaltons) are indicated
on the left.
|
|
Expression of the deletion mutant gD in the culture
supernatant.
To reduce the nonspecific reaction we have next
attempted to express the gD protein that would be secreted to the
culture fluid. We therefore introduced a stop codon immediately
adjacent to the first amino acid of the TM region of gD (Fig. 1). The
plasmid DNA coding for the secretory form of gD was transfected to
the COS7 cells, and the cells were subjected to immunofluorescence staining. Significant signals were observed in the cells (data not
shown). In order to know whether the mutant protein was properly expressed and secreted into medium of the transfected-cell culture, the
cells were labeled with the Redivue Pro-mix
L-[35S] in vitro cell- labeling mix, and
the clarified supernatant was analyzed by SDS-PAGE (Fig.
5). A band with a molecular mass corresponding to the truncated form of gD was detected when the medium of cells transfected with the deletion mutant gD was
directly subjected to SDS-PAGE (Fig. 5, lane 5). Media obtained
from cells transfected with neither pBgD nor pcDNA3.1(
)
gave signals upon SDS-PAGE analysis (Fig. 5, lane 4 or 6, respectively). The culture media were then used as antigen in RIPA.
Whereas a single discrete band was detected in the medium from cells
transfected with pBgDdTM (Fig. 5, lane 2), no protein was
precipitated when the media from cells transfected with pBgD or
pcDNA3.1(
) (Fig. 5, lane 1 or 3, respectively) were examined. These
results indicated that the gD protein lacking TM and CT was secreted
into the culture medium without apparent loss of antigenicity.

View larger version (84K):
[in this window]
[in a new window]
|
FIG. 5.
Expression of the secretory form of gD. The culture
fluids from COS7 cells transfected with pBgD (lanes 1 and 4),
pBgDdTM (lanes 2 and 5), or pcDNA3.1( ) (lanes 3 and 6) and then
labeled with [35S] were subjected to SDS-PAGE directly
(lanes 4 to 6) or after immunoprecipitation with anti-gD(SA8) serum
(lanes 1 to 3). The position of gDdTM is indicated on the left, and
molecular mass standards (in kilodaltons) are shown on the right.
|
|
Reactivity of gDdTM to monkey sera by WB or dot blot
method.
The culture supernatant of COS7 cells transfected with the
pBgDdTM or vector plasmid was applied to the SDS-PAGE, and
the separated proteins were transferred to a PVDF membrane. The
membrane was separated into strips, and the strips were incubated with sera from monkeys. As expected, no nonspecific band was detected (Fig.
6B), indicating that the culture
supernatant contained a minimal amount of cellular proteins. As shown
in Fig. 6A, however, five out of eight positive sera (no. 37, 41, 49, 83, and 84) showed reduced reactivity in WB analysis using the
lysate from cells transfected with pBgD. Since it seemed likely
that stringent conditions used in the WB affected the antigenicity, we
next employed the dot blot assay, which did not involve a transfer
process of the proteins in the denaturing buffer.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 6.
Reactivity of the secretory form of gD, gDdTM, with
monkey sera in WB analysis. Culture media from COS7 cells transfected
with pBgDdTM (A) or pcDNA3.1( ) (B) were examined for their
reactivities with monkey sera. The position of gDdTM (arrow) and
molecular mass standards (in kilodaltons) are indicated on the left.
|
|
We first tested the same set of sera used in the experiment mentioned
above using purified gDdTM as the antigen. The results
were shown
in Fig.
7. All eight sera (no. 37 to 84)
from monkeys
that had been regarded as being infected with B virus
reacted
well with both the purified protein (Fig.
7, position
a) and culture
supernatant (Fig.
7, position b) blotted
directly onto the membrane.
No signal was observed when the
membrane was spotted with a culture
fluid from cells transfected
with pcDNA3.1(

) (Fig.
7, position
c). Five sera (no. 991 to
995) from uninfected monkeys did not
show significant reactivity
against any antigen, including unpurified
gDdTM. Therefore, we used the
culture fluid from cells transfected
with pBgDdTM as the antigen
without purification in the dot blot
method to test additional monkey
sera. Sixty-one sera from monkeys
that had been regarded as positive by
ELISA using inactivated
B virus-infected cell lysate showed significant
positive signals
to the culture fluid containing gDdTM but not to the
vector control
in dot blot analysis. Thirty-six negative sera showed
significant
signals neither to gDdTM nor to the vector control.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 7.
Detection of antibody to the secretory form of gD,
gDdTM, in monkey sera by the dot blot method. The position of the
purified gDdTM (a), culture supernatant from COS7 cells transfected
with pBgDdTM (b), or vector DNA (c) on each membrane is
schematically indicated in the inset box. After blocking, each membrane
was incubated with individual monkey serum.
|
|
 |
DISCUSSION |
Since B virus infection often results in devastating and fatal
disease, establishment of macaque colonies free from B virus is
urgently required. Although serological surveillance of a herd of
macaques seems to be a powerful tool to detect B virus infection, it has been hampered to obtain B virus-specific antigens because a
biosafety level 4 facility is necessary for propagation of live virus. To circumvent this problem we attempted to express one of the
major glycoproteins of B virus, gD, in mammalian
cells. The B virus gD gene was therefore subcloned into the expression vector pcDNA3.1(
) downstream of the cytomegalovirus promoter. The nucleotide sequencing of the insert revealed that three nucleotides that were reported before at positions 891, 898, and 907 (the number 1 is A of the initiation codon of gD) were missing
(1). The nucleotide deletions resulted in one amino
acid deletion at position 303 as well as amino acid
substitutions at positions 297 to 302 (data not shown).
Upon transfection of the recombinant plasmid DNA into COS7 cells, the
protein that reacted with the antibody against gD raised against
gel-purified gD of SA8 or inactivated B virus was detected in
transfected cells by RIPA. RIPA revealed that the protein also reacted
with sera from monkeys which had been shown to be infected with B virus
by an ELISA using inactivated B virus-infected cell lysate. These
observations indicated that the gD protein expressed from plasmid DNA
was antigenically indistinguishable from that synthesized in
virus-infected cells.
We next tried to use the expressed gD in WB analysis, since the method
did not require any radioactive materials. Reduced reactivities,
however, were noticed for some sera. Nonspecific binding to possible
cellular components was also noticed. The reduced reactivities of some
sera observed in WB analysis was probably due to the loss of the
antigenic epitopes on gD under the condition utilized in PAGE and
membrane transfer. Monoclonal antibodies to the discontinuous
epitopes of gD of HSV-1 were previously reported to lose their
reactivities to gD in the WB analysis (3, 5).
We attempted to express a secretory form of gD lacking TM and CT to
minimize contaminating cellular component. Upon transfection of COS7
cells with the plasmid pBgDdTM, mutant gD was secreted into the
culture fluid. The secreted proteins were shown to react not only with
anti-gD(SA8) and anti-B virus rabbit serum but also with sera from a
monkey that had been shown by RIPA to be seropositive for B virus (data
not shown). As expected, nonspecific reactions to the cellular
components were hardly observed in WB analysis. Since some sera still
showed reduced reactivities to the secretory form of gD in WB and since
the culture fluid exclusively containing truncated gD showed comparable
reactivity in terms of specificity and sensitivity, dot blot analysis
was employed. The results from the experiments using a large number of
monkey sera indicated that this dot blot assay could be applied to the
detection of B virus antibody in the monkey sera. Although we have
analyzed only one viral component, our data indicated that gD was one
of the most useful antigens for serodiagnosis of B virus infection in monkeys.
 |
ACKNOWLEDGMENTS |
We are indebted to Alice Bennett (Defense Evaluation and Research
Agency, Chemical and Biological Defense) for kindly providing a plasmid
containing the gD gene of B virus and to Richard Eberle (Oklahoma State
University) for providing anti-gD and anti-B virus sera. We also thank
Koji Fujimoto and Toyoko Narita (The Corporation for Production and
Research of Laboratory Primates) for measuring the serum antibody by
ELISA using inactivated B virus antigen.
This work was supported in part by a grant from the Ministry of Health
and Welfare.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Tsukuba Primate
Center for Medical Science, National Institute of Infectious Diseases, 1 Hachimandai, Tsukuba, Ibaraki 208-0843, Japan. Phone: 81-298-37-2121. Fax: 81-298-37-0218. E-mail: ktana{at}nih.go.jp.
 |
REFERENCES |
| 1.
|
Bennett, A. M.,
L. Harrington, and D. C. Kelly.
1992.
Nucleotide sequence analysis of genes encoding glycoproteins D and J in simian herpes B virus.
J. Gen. Virol.
73:2963-2967[Abstract/Free Full Text].
|
| 2.
|
Bennett, A. M.,
M. J. Slomka,
D. W. G. Brown,
G. Lloyd, and M. Mackett.
1999.
Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D.
J. Med. Virol.
57:47-56[CrossRef][Medline].
|
| 3.
|
Cohen, G. H.,
V. J. Isola,
J. Kuhns,
P. W. Berman, and R. J. Eisenberg.
1986.
Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.
J. Virol.
60:157-166[Abstract/Free Full Text].
|
| 4.
|
Eberle, R.,
D. Black, and J. K. Hilliard.
1989.
Relatedness of glycoproteins expressed on the surface of simian herpesvirus virions and infected cells to specific HSV glycoproteins.
Arch. Virol.
109:233-252[CrossRef][Medline].
|
| 5.
|
Eisenberg, R. J.,
D. Long,
M. Ponce de Leon,
J. T. Mattews,
P. G. Spear,
M. G. Gibson,
L. A. Lasky,
P. Perman,
E. Golub, and G. H. Cohen.
1985.
Localization of epitopes of herpes simplex virus type 1 glycoprotein D.
J. Virol.
53:634-644[Abstract/Free Full Text].
|
| 6.
|
Hilliard, J. K., and J. A. Ward.
1999.
B-virus specific-pathogen-free breeding colonies of macaques (Macaca mulatta): retrospective study of seven years of testing.
Lab. Anim. Sci.
49:144-148[Medline].
|
| 7.
|
Ohsawa, K.,
T. W. Lehenbauer, and R. Eberle.
1999.
Herpesvirus papio 2: alternative antigen for use in monkey B virus diagnostic assays.
Lab. Anim. Sci.
49:605-616[Medline].
|
| 8.
|
Roizman, B.
1996.
Herpesviridae, p. 2221-2230.
In
B. N. Fields, D. K. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 9.
|
Slomka, M. J.,
L. Harrington,
C. Arnold,
J. P. N. Norcott, and D. W. G. Brown.
1995.
Complete nucleotide sequence of the herpesvirus simiae glycoprotein G gene and its expression as an immunogenic fusion protein in bacteria.
J. Gen. Virol.
76:2161-2168[Abstract/Free Full Text].
|
| 10.
| Takano, J., T. Narita, K. Fujimoto, R. Mukai, and A. Yamada. Detection of B virus infection in cynomolgus monkeys by
ELISA using simian agent 8 as alternative antigen. Exp. Animals, in
press.
|
| 11.
|
Tanabayashi, K., and R. W. Compans.
1996.
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion.
J. Virol.
70:6112-6118[Abstract/Free Full Text].
|
| 12.
|
Ward, J. A., and J. K. Hilliard.
1994.
B virus-specific pathogen-free (SPF) breeding colonies of macaques: issues, surveillance, and results in 1992.
Lab. Anim. Sci.
44:222-228[Medline].
|
| 13.
|
Ward, J. A.,
J. K. Hilliard, and S. Pearson.
2000.
Herpes B-virus specific-pathogen-free breeding colonies of macaques (Macaca mulatta): diagnostic testing before and after elimination of the infection.
Comp. Med.
50:317-322[Medline].
|
| 14.
|
Weigler, B. J.
1992.
Biology of B virus in macaque and human hosts: a review.
Clin. Infect. Dis.
14:555-567[Medline].
|
| 15.
|
Whitley, R. J.
1996.
Cercopithecine herpes virus 1 (B virus), p. 2623-2635.
In
B. N. Fields, D. K. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
Journal of Clinical Microbiology, September 2001, p. 3025-3030, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3025-3030.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fujima, A., Ochiai, Y., Saito, A., Omori, Y., Noda, A., Kazuyama, Y., Shoji, H., Tanabayashi, K., Ueda, F., Yoshikawa, Y., Hondo, R.
(2008). Discrimination of Antibody to Herpes B Virus from Antibody to Herpes Simplex Virus Types 1 and 2 in Human and Macaque Sera. J. Clin. Microbiol.
46: 56-61
[Abstract]
[Full Text]
-
Perelygina, L., Patrusheva, I., Hombaiah, S., Zurkuhlen, H., Wildes, M. J., Patrushev, N., Hilliard, J.
(2005). Production of Herpes B Virus Recombinant Glycoproteins and Evaluation of Their Diagnostic Potential. J. Clin. Microbiol.
43: 620-628
[Abstract]
[Full Text]